PIK3CA and adenocarcinoma: Additionally, data generated from cBioPortal (Figure 1D) revealed that the PIK3CA mutation showed a high alteration rate in squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma and mucinous adenocarcinoma compared to endometrioid carcinoma.